Analysts chose stocks from financial services, construction, pharmaceutical, and financial technology spaces for Friday’s session.

Centrum Broking Technical and Derivatives Research Head and Assistant Vice President Nilesh Jain, Axis Securities Technical and Derivatives Research Senior Vice President Rajesh Palviya, and Amit Ventures Founder Amit Goel shared views on the above mentioned stocks.

DCB Bank 

Jain recommended a ‘buy’ for the stock. The target price for the counter is Rs 152 apiece, which implied 4.6% upside from Thursday’s close. The stop loss for the counter is Rs 141 apiece.

Twenty-two analysts tracking the company maintain a ‘buy’ rating, according to Bloomberg data. The average 12-month consensus price target implies an upside of 11.2%.

Anant Raj

Centrum Borking’s Jain recommends buying Anant Raj stock. The target price for the counter is Rs 563, which implied 3.2% upside from Friday’s closing price. The stop loss for the counter is Rs 535 apiece.

Five analysts tracking the company maintain a ‘buy’ rating, according to Bloomberg data. The average 12-month consensus price target implies an upside of 63.8%.

Glenmark Pharmaceuticals 

Palviya recommends a ‘buy’ for the stock. The target price for the counter is Rs 1,445 apiece, which implied a 2.4% upside from Thursday’s close. The stop loss for the stock is Rs 1,387 apiece.

Out of 12 analysts tracking the company, eight maintain a ‘buy’ rating, three recommend a ‘hold’ and one suggests to ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 19.1%.

Paytm

Palviya has a ‘buy’ call on Paytm parent One97 Communications Ltd. The target price for the counter is Rs 900, which implied 2.3% upside from Friday’s close price. The stop loss for the stock is Rs 865 apiece.

Out of 19 analysts tracking the company, nine maintain a ‘buy’ rating, seven recommend a ‘hold’ and three suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 7.4%.

Shree Cement 

Amit Goel recommends ‘buy’ for Shree Cement Ltd. The target price for the counter is Rs 120 apiece, which implied 3% upside from Thursday’s close. The stop loss for the stock is Rs 29,300 apiece.

Out of 42 analysts tracking the company, 15 maintain a ‘buy’ rating, 16 recommend a ‘hold’ and 11 suggest ‘sell’, according to Bloomberg data. The average 12-month consensus price target implies an upside of 1.7%.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.

. Read more on Markets by NDTV Profit.Find out Centrum Broking, Axis Securities, and Amit Ventures’ view about Anant Raj, Paytm, DCB Bank, Shree Cement, and Glenmark Pharmaceuticals.  Read MoreMarkets, Business, Notifications 

​NDTV Profit